Galderma online survey reveals essential COVID-19 mask wearing can be worsening rosacea skin disease

Galderma

PR88143

 

LAUSANNE, Switzerland, Feb. 19, 2021 /PRNewswire=KYODO JBN/ --

 

- Although essential for public health, new online survey findings show that

people with self-reported rosacea* may be experiencing worsening of symptoms

due to mask wearing, further increasing the daily burden for people living with

this chronic skin disease

- Despite worsening of signs and symptoms, only a third (33%) of respondents

have visited a healthcare provider (HCP) in person since the pandemic began

 

The COVID-19 pandemic has made mask wearing commonplace in many parts of the

world, but for those suffering with facial skin disease, this can bring

additional challenges. A recent survey conducted by Galderma suggests that the

pandemic may impact rosacea patients, from worsening of signs and symptoms

related to mask wearing, to reduced HCP consultations.[1]

 

Although essential for public health, findings from the new online survey

involving 220 respondents* from Canada and Germany reveal that almost two

thirds (63%) are experiencing worsening of their symptoms related to mask

wearing, including redness (75%), pimples and/or pustules (72%) and more

flare-ups (53%).[1]

 

A recent independent clinical study in Italy, investigating the impact of mask

wearing in rosacea and acne vulgaris patients, also found that prolonged use of

face masks increases disease severity and significantly impacts the quality of

life of rosacea and acne patients.[2]

 

Despite worsening of symptoms, over 1 in 2 (52%) people surveyed* admitted

using mask wearing as a way to hide their disease, and 40% are not going out as

often in order to avoid wearing a mask. The survey also revealed that almost a

third (30%) are spending more time on their skincare routine during the

pandemic.

 

Additionally, nearly half (48%) have changed how they manage their disease

since mask wearing, with 51% trying a non-prescription product and only 27%

having been prescribed a new treatment by a HCP.[1]

 

Aliene Noda, Global Medical Franchise Lead Rosacea and Onco-Dermatology

Prescription GBU, Galderma, comments on these findings: "With just a third of

rosacea sufferers surveyed booking an appointment with their HCP during the

pandemic, there is a huge cause for concern. Our survey suggests that more

patients may be self-treating which could mean they are using products that are

not specifically tailored for their skin disease and this could, ultimately, do

more harm than good."

 

Prof. Dr Jerry Tan, Adjunct Professor, Western University, Ontario, Canada,

says: "During the current pandemic, self-medication and inadequate use of

prescribed rosacea treatments are concerning. Many rosacea sufferers are hiding

their rosacea under a mask to reduce embarrassment. This could however also be

worsening their rosacea. If you are suffering from rosacea, do not be afraid to

book an appointment with your HCP via phone, video or in-person if possible. It

is important to adhere to prescribed treatments and seek professional support

if you are experiencing worsening of signs and symptoms because of mask

wearing."

 

The survey shows that only a third (33%) of respondents have visited their HCP

in person since the pandemic began, with only 8% having a video consultation.

Of those who have not booked an appointment, 47% stated they have not wanted to

book an appointment, whilst 21% have been unable to book one.[1]  

      

*Based on a self-administered survey of www.FaceUpToRosacea.com and

www.stelldichdeinerrosacea.de email subscribers during December 2020 – January

2021. 87% of whom state that they have a rosacea diagnosis from a healthcare

provider. 13% believe that they have rosacea but are not yet diagnosed

 

References:

1.  Data on file. Online survey of faceuptorosacea.com and

stelldichdeinerrosacea.de https://www.stelldichdeinerrosacea.de/email

subscribers (220 respondents from Canada and Germany)

2.  Damiani G, et al. Dermatol Ther. 2021 Feb. DOI: 10.1111/dth.14848. [Epub

ahead of print].

 

About rosacea

Rosacea is a common inflammatory skin disease that presents variable clinical

characteristics, of which the most common are flushing, persistent erythema,

and inflammatory lesions. It mainly affects the central areas of the face, such

as the cheeks and nose. The disease can affect both adult men and women,

usually after the age of 30. Additionally, symptoms such as stinging, burning

and increased sensitivity of the skin are common. The eyes are often affected,

and might present as red, dry or itchy.

 

Although the cause of the disease is still under debate, various trigger

factors are known, including spicy foods, alcohol, emotional stress,

sun/UV-exposure, hot baths and beverages. Demodex, generally harmless mites,

can also be found in the skin in an elevated quantity in people with rosacea.

 

Rosacea may worsen over time if left untreated. People that suspect they suffer

from rosacea should visit their dermatologist or healthcare provider for

diagnosis and discuss what treatment is right for them. Because rosacea is a

highly visible disease, it is known to cause embarrassment and anxiety in some

patients, which in turn may cause frustration and have a negative impact on

their social life.

 

About Galderma

Galderma, the world's largest independent global dermatology company, was

created in 1981 and is now present in over 100 countries with an extensive

product portfolio of prescription medicines, aesthetic solutions and consumer

care products. The company partners with health care practitioners around the

world to meet the skin health needs of people throughout their lifetime.

Galderma is a leader in research and development of scientifically-defined and

medically-proven solutions for the skin. For more information, please visit

www.galderma.com.

 

(C) 2021 Galderma S.A. All Right Reserved. All trademarks are the property of

their respective owners

 

Source: Galderma

 

本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。

このプレスリリースには、報道機関向けの情報があります。

プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。

プレスリリース受信に関するご案内

SNSでも最新のプレスリリース情報をいち早く配信中